Great to be an Invited Faculty member at the TCTAP 2025 conference in Seoul Korea. Topics included:

IVUS Guided CTO PCI – Wiring and Stent Optimisation

Optimal Management of ACS Patients Presenting With a Large Thrombus
Burden

Provisional Stenting in Left Main vs. Non- Left Main Complex Bifurcation Stenoses: Is There a Difference?

When You Stop CTO PCI

1. Heart failure remains a leading cause of death and disability globally.The 2022 AHA/ACC/HFSA guideline for the Management of Heart Failure (A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines) has just been released. The document outlines an up-to-date, evidence based approach to managing patients with heart failure and contains the following main take home messages:

Guideline-directed  medical  therapy  (GDMT)  for  heart  failure  (HF)  with  reduced  ejection  fraction  (HFrEF)  now  includes  4  medication  classes  that  include:

1. Angiotensin-converting enzyme inhibitor (ACEi) / angiotensin receptor blocker (ARB) / angiotensin receptor-neprilysin inhibitor (ARNi)

2. Mineralcorticoid receptor antagonist (MRA)

3. Beta-blocker

4. Sodium-glucose cotransporter-2 inhibitors (SGLT2i)

At maximum tolerated doses with a diuretic as needed. Use of SGLT2i are recommended  for heart failure with preserved ejection fraction  (HFpEF) 

https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000001063

2. First Experience Using the Sheathless Hyperion Guiding Catheter System Designed for Direct Insertion. Journal of Interventional Cardiology. 2022 Feb 22;2022 Andrew Borrie , Sarah Fairley , and Scott A. Harding

Publication link https://doi.org/10.1155/2022/5668728

Wellington Hospital, Wellington, New Zealand

Radial access has many benefits for patients including greater comfort and reduced complications. Some operators have been reluctant to perform complex interventions through the radial artery citing lack of guide back-up and limitations in the size of the guiding catheter that can be used via the radial route. Sheathless guide catheters have the potential to overcome these problems and Prof Harding has worked with Asahi Intecc in the development of the Sheathless Hyperion guide catheter designed specifically for PCI using the radial artery as access. Prof Harding and colleagues recently published a paper reporting the first clinical experience with the Sheathless Hyperion Guide catheter. This study demonstrated that complex PCI could be performed via the radial artery with high success rates and low complication rates when using the Sheathless Hyperion.

3. Check out the latest on Lipid Management in the Research Review Educational Series NZ

4. Prof Harding developed a new technique to facilitate precise placement of ostial stents using real time IVUS Guidance. Publication link. https://lnkd.in/gkT_tka